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Abstract
Background: Knowledge of the fetal effects of maternal medication use in pregnancy is often inadequate and current pregnancy
pharmacovigilance (PV) surveillance methods have important limitations. Patient self-reporting may be able to mitigate some of
these limitations, providing an adequately sized study sample can be recruited.
Objective: To compare the ability and cost-effectiveness of several direct-to-participant advertising methods for the recruitment
of pregnant participants into a study of self-reported gestational exposures and pregnancy outcomes.
Methods: The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT)
pregnancy study is a non-interventional, prospective pilot study of self-reported medication use and obstetric outcomes provided
by a cohort of pregnant women that was conducted in Denmark, the Netherlands, Poland, and the United Kingdom.
Direct-to-participant advertisements were provided via websites, emails, leaflets, television, and social media platforms.
Results: Over a 70-week recruitment period direct-to-participant advertisements engaged 43,234 individuals with the study
website or telephone system; 4.78% (2065/43,234) of which were successfully enrolled and provided study data. Of these 90.4%
(1867/2065) were recruited via paid advertising methods, 23.0% (475/2065) of whom were in the first trimester of pregnancy.
The overall costs per active recruited participant were lowest for email (€23.24) and website (€24.41) advertisements and highest
for leaflet (€83.14) and television (€100.89). Website adverts were substantially superior in their ability to recruit participants
during their first trimester of pregnancy (317/668, 47.5%) in comparison with other advertising methods (P<.001). However, we
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identified international variations in both the cost-effectiveness of the various advertisement methods used and in their ability to
recruit participants in early pregnancy.
Conclusions: Recruitment of a pregnant cohort using direct-to-participant advertisement methods is feasible, but the total costs
incurred are not insubstantial. Future research is needed to identify advertising strategies capable of recruiting large numbers of
demographically representative pregnant women, preferentially in early pregnancy.
(JMIR Public Health Surveill 2016;2(1):e13)   doi:10.2196/publichealth.5366
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Introduction
Medication Use in Pregnancy
Maternal medication use during pregnancy is common [1] and
is thought to have increased substantially over the last 30 years
[2]. However, adequate nonconflicting clinical evidence
concerning the fetal effects of maternal medication use in
pregnancy takes many years to collect [3]. Safety data is
therefore often lacking, particularly for newly marketed
medications [3], and this may impact upon both maternal
medication compliance [4] and health care professional
prescribing [5]. The paucity of data and the potential
consequences this may have for both maternal and fetal health,
thereby identifies a clear need for improved pharmacovigilance
(PV) research in the field. For ethical reasons, and in order to
provide sufficient statistical power, this research is
predominantly performed using post-marketing
pharmacoepidemiological (PE) approaches [6]. However, many
of the more commonly used PE methods have been associated
with numerous biases and limitations [7] highlighting the need
for novel PE approaches to pregnancy PV research.
Pregnancy Pharmacovigilance
The direct collection of health and medication use data from
medicines consumers has proven beneficial in the monitoring
of adverse drug reactions [8-10]. Therefore, gestational exposure
and pregnancy outcome data collected in a prospective manner
directly from pregnant women may provide a useful data source
for pregnancy PV research. In 2009, a large collaborative
European research program, the Pharmacoepidemiological
Research on Outcomes of Therapeutics by a European
Consortium (PROTECT) project [11], was funded with the aim
of addressing key methodological limitations in PV/PE research.
One of the specific aims of the PROTECT project was to explore
the feasibility of enhancing the early detection of adverse drug
reactions using modern communication methods to collect PV
surveillance data. Through employing modern communication
techniques in pregnancy PV research, such as website reporting,
it may be possible to collect data from a large number of study
participants in a manner, which is less researcher time intensive
than some traditional epidemiological methods [12]. As data
are collected directly from the patient, it may also be reasonable
to expect fewer misclassification errors, particularly for socially
sensitive details, such as use of alcohol, tobacco, or illicit drugs,
or details regarding over-the-counter medication, which are not
easily collected from population-based registers of health care
data. More specifically for pregnancy PV studies, as
self-reporting does not require notification of pregnancy to a
health professional, data reported directly from a patient could
be collected earlier in pregnancy; hence, providing surveillance
over a time period not easily covered by some of the common
PV/PE surveillance techniques.
Study Objectives
Given these potential advantages, the PROTECT pregnancy
study was designed to explore whether pregnant women could
be recruited to self-provide detailed information to an automated
data collection tool, thereby enabling the prospective collection
of gestational medication use, lifestyle details, and pregnancy
outcomes. Here, we describe recruitment achieved by the
direct-to-participant advertisement methods used to recruit
participants to this study and compare their cost-effectiveness
and the stage of pregnancy at which these methods recruited
participants to the study.
Methods
PROTECT Pregnancy Study
The PROTECT pregnancy study is a prospective,
non-interventional descriptive pilot-study of self-reported
medication use and obstetric outcomes as provided by a cohort
of pregnant women. The research protocol was created by a
collaboration of public and private institutions, with researchers
from public health authorities and academic institutions leading
the research in each of the four study locations: Denmark, the
Netherlands, Poland, and the United Kingdom. Ethical review
of the study was required in Poland (Ethics Committee of the
Poznań University of Medical Sciences) and the United
Kingdom (National Research Ethics Service Committee North
East - Sunderland). In the Netherlands as the data being collected
were considered anonymous the study was granted an ethical
review waiver from a regional research assessment board
(Regionale Toetsingscommissie Patiëntgebonden Onderzoek,
Leeuwarden), while in Denmark non-interventional
epidemiological surveys are considered exempt from the
requirement for ethical review [13].
Study Participants
All study participants were required to provide informed consent
for participation. In Denmark, the Netherlands, and the United
Kingdom informed consent to participate was provided
electronically. In Poland, participants were required to provide
hand signed declarations of consent via forms printed from the
website and mailed to the local study team.
JMIR Public Health Surveill 2016 | vol. 2 | iss. 1 | e13 | p.2http://publichealth.jmir.org/2016/1/e13/
(page number not for citation purposes)
Richardson et alJMIR PUBLIC HEALTH AND SURVEILLANCE
XSL•FO
RenderX
Participants were asked to provide information via a series of
self-completed questionnaires using either a secure website or
a telephone-based interactive voice recognition system (IVRS).
Questionnaires were completed at study entry, over the duration
of their pregnancy (completed every 2-4 weeks with the
frequency decided by the participant at study entry) and shortly
following the expected date of delivery (EDD) by website
participants, or at study entry and shortly following the EDD
only by IVRS participants. For pregnancies that ended prior to
the EDD, participants reported they were no longer pregnant at
their 2 or 4 weekly information request. Participants were also
free to discontinue their participation at any stage, providing
notification either by email or telephone.
For inclusion in the study participants were required to be
currently pregnant, residing in one of four study countries, to
have adequate natural language skills for that country, have
internet or telephone access, and to be of legal age for the
provision of their consent to participate (Denmark, Netherlands,
and Poland – 18 years; United Kingdom – 16 years). In Denmark
there was an additional requirement for participants to provide
their civil registration number.
Study Sample Size
Because this was an exploratory pilot study, an arbitrary target
sample size of 4800 women (1200 per study location) was
selected with the goal of recruiting participants over a 104-week
period. However, due to time delays in obtaining the necessary
approvals the recruitment period was reduced to 70 weeks.
Study Recruitment and Data Collection
Participants were recruited from October 1, 2012 (recruitment
week 1) until January 31, 2014 (recruitment week 70) in
Denmark, the Netherlands, and the United Kingdom. Due to
difficulties in arranging ethical approvals, the start date in
Poland was further delayed until May 20, 2013 (recruitment
week 34). Follow-up data, which are not further considered in
this manuscript were collected from all participants until March
28, 2014. Participants received no incentives for enrolment or
retention.
Recruitment Strategies
A key recruitment objective was to use direct-to-participant
advertisements wherever possible to recruit women early in
their pregnancy, and at low or no cost. In the first 18 weeks of
the recruitment period, low/no-cost advertisement methods were
used in Denmark, the Netherlands, and the United Kingdom.
These included posting promotional discussion topics in
pregnancy online forums (United Kingdom – no cost), placing
small hyperlinks on pregnancy-related websites (Netherlands
– no cost), displaying leaflets and posters in community
pharmacies and/or obstetric/midwifery units (Netherlands and
United Kingdom – printing and delivery costs), communication
through a social media profile (Facebook United Kingdom –
no cost), and banner advertising in a pregnancy-specific section
of a popular health and wellbeing website (Denmark – low cost).
Subsequently, additional funding was provided for higher cost
advertising methods, which included large digital banners
(Denmark), hyperlinks (Netherlands), and small picture/text
graphics (United Kingdom) placed on prominent pregnancy
specific websites, adverts in emails sent to registered users of
widely used pregnancy/health information, and parenting
websites (all locations), an advert aired on
regional/digital-Internet television channels (Poland), a full-page
article in a regional newspaper and pregnancy magazine
(Poland), and paid advertising on a social media site (Facebook
– targeting British women aged 16-45 with interests in children,
pregnancy, and health). Several examples of the adverts used
to promote the study are provided in the supplementary
appendix.
Advertisement Method Cost-Effectiveness Analysis
To compare the international advertising costs, conversion of
local currencies to Euros was performed using the exchange
rate on March 10, 2014 (Euro:DKR 0.13, Euro:PZ 0.24,
Euro:GBP 1.20, Euro:USD 0.72). Only advertising methods
with associated costs (paid advertising methods) displayed via
similar media platforms were grouped for comparison in this
analysis. The cost-effectiveness of the various paid
advertisement methods were compared as total cost per
participant recruited (€ per participant).
Stage of Pregnancy at Enrolment Analysis
All participants were requested to provide their EDD. Using
this, the date of the last menstrual period (LMP; EDD-280 days)
was calculated and the date of enrolment was defined as being
within the first (1-90 days post-LMP) or second/third trimester
(91-280+ days post-LMP). The proportion of participants in
their first trimester at enrollment was compared between study
locations and paid advertisement methods using Poisson
regression (P<.05 indicating statistical significance). Statistical
analysis was performed using Stata Version 13.1 [14].
Results
Participant Recruitment
In total the advertisements generated traffic of 43,220 unique
subjects to the study website and 14 calls to the IVRS over the
70-week recruitment period. Of these women, 5.83%
(2521/43,220) self-enrolled and began data entry. However,
455, including 13 of 14 who chose to provide data via the IVRS,
did not complete the study entry questionnaire. As insufficient
information was available from these participants, and only a
single participant used the IVRS system, only the details of the
2065 active study participants who completed the study entry
questionnaire via the website are discussed further (Denmark
n=639, Netherlands n=476, Poland n=241, and the United
Kingdom n=709).
Figure 1 below describes the total number of active study
participants joining the study in each week of the recruitment
period. The low/no-cost advertisements used over the first 18
weeks of recruitment attracted a smaller than expected number
of visitors to the website (n=1278), of which only 4% (52/1278)
enrolled and provided study data. This prompted the use of
higher cost advertisement methods, and Figure 1 clearly
demonstrates the improvement in recruitment following their
implementation (week 19+).
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Figure 1. Timeline of participant recruitment (large scale email advertisements at weeks 19, 55, 60, and 64).
Also, clearly seen from Figure 1 are the large increases in
recruitment, which were observed during weeks 19, 55, 60, and
64, which were mainly produced by the large scale email
advertisement campaigns where in excess of 100,000 emailed
adverts were broadcast.
Advertisement Method Cost-Effectiveness
Of the 2065 active study participants, 1867 were recruited
through paid advertisements, which broadly fit into the following
five categories: website advertisements, email broadcasts, leaflet
promotions, television broadcasts, and social media
advertisements. A description of the costs incurred for each of
these categories, the number of participants recruited, and the
resulting cost-per-participant is provided in Table 1. Where
available we have also provided estimates of the total impact
of the advertisements. For website/paid social media
advertisements, we display the total number of advert
impressions (ie, the number of times advertisement were
displayed to users), for emails the total number broadcast, and
for leaflets the total number printed.
JMIR Public Health Surveill 2016 | vol. 2 | iss. 1 | e13 | p.4http://publichealth.jmir.org/2016/1/e13/
(page number not for citation purposes)
Richardson et alJMIR PUBLIC HEALTH AND SURVEILLANCE
XSL•FO
RenderX
Table 1. Number of active participants recruited by each of the paid advertisement methods.
All locationsUnited KingdomPolandNetherlandsDenmarkAdvertisement Methods
All Paid Methods
56,727.0016,962.0010,843.0019,010.009912.00Total expenditure (€)
1867682125446614Participants recruited (n)
30.3824.8786.7442.6216.14Cost per participant (€)
Website
16,376.00576.00276.006002.009522.00Total expenditure (€)
2,877,338567,556183,6521,7892,124,341Total impressions (n)
668202232594Participants recruited (n)
24.5228.8012.55187.5616.03Cost per participant (€)
Email
23,128.0010,022.005304.007412.00390.00Total expenditure (€)
309,156120,44294,50080,21414,000Total emails sent (n)
9955824734620Participants recruited (n)
23.2417.22112.8521.4219.50Cost per participant (€)
Leaflet
16,129.006178.004355.005596.00-Total expenditure (€)
47,88013,25019,85015,030-Total leaflets printed (n)
194794768-Participants recruited (n)
83.1478.2092.6682.29-Cost per participant (€)
Television
908.00-908.00--Total expenditure (€)
9-9--Participants recruited (n)
100.89-100.89--Cost per participant (€)
Paid Social Media
186.00186.00---Total expenditure (€)
135,305135,305---Total impressions (n)
11---Participants recruited (n)
186.00186.00---Cost per participant (€)
In total, €56,727 was spent on the paid advertising methods,
which equated to €30.38 per active participant. In comparing
the five broad categories of paid advertisements across all
countries, the least cost-effective were social media (€186.00),
television advertisements (€100.89), and leaflet advertising
(€83.14), while website and email advertisements were the most
cost-effective at €24.41 and €23.24, respectively. However,
there were considerable international variations in the
cost-effectiveness of the broad advertisement categories (Table
1). For example the cost-per-participant for website advertising
in Denmark (€16.03), Poland (€12.54), and the United Kingdom
(€28.80) was low in comparison with the Netherlands (€187.56),
while for email advertising, costs in Poland were high (€112.85)
in comparison with Denmark (€19.50), the Netherlands (€21.42),
and the United Kingdom (€17.22). Leaflet advertising costs
were found to be similar across the three study locations where
they were used (Netherlands €82.29, Poland €92.66, United
Kingdom €78.20).
Recruitment of Participants in Early Pregnancy
Of the 2065 active participants recruited to the study 23.0%
(475/2065) were in their first trimester at enrolment. Table 2
reports the number of active participants recruited by gestational
age at enrolment stratified by study location. A Poisson
regression comparing the proportion of first trimester enrolled
participants across the locations identified a statistically
significant difference (P<.001) driven by the high proportion
of first trimester active participants recruited from Denmark
(309/330, 48.4%) in comparison with the lower proportions
recruited from the Netherlands (48/476, 10.1%), Poland (48/193,
19.9%), and the United Kingdom (70/709, 9.87%).
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Table 2. Stage of pregnancy at which active participants were recruited to the study (SOP, stage of pregnancy, participants recruited in the second or
third trimesters had reached at least 13-weeks’ gestation)
All LocationsUnited KingdomPolandNetherlandsDenmarkSOP
n (%)n (%)n (%)n (%)n (%)
475 (23.0%)a70 (9.9%)48 (19.9%)48 (10.1%)309 (48.4%)First trimester
63 (3.1%)0 (0.0%)3 (1.2%)2 (0.4%)58 (9.1%)≤4/40
61 (3.0%)4 (0.6%)4 (1.7%)0 (0.0%)53 (8.3%)5/40
64 (3.1%)4 (0.6%)5 (2.1%)2 (0.4%)53 (8.3%)6/40
46 (2.2%)2 (0.3%)5 (2.1%)2 (0.4%)37 (5.8%)7/40
48 (2.3%)7 (1.0%)8 (3.3%)4 (0.8%)29 (4.5%)8/40
52 (2.5%)14 (2.0%)0 (0.0%)15 (3.2%)23 (3.6%)9/40
42 (2.0%)8 (1.1%)4 (1.7%)9 (1.9%)21 (3.3%)10/40
50 (2.4%)15 (2.1%)9 (3.7%)6 (1.3%)20 (3.1%)11/40
49 (2.4%)16 (2.3%)10 (4.2%)8 (1.7%)15 (2.4%)12/40
1590 (77.0%)639 (90.1%)193 (80.1%)428 (89.9%)330 (51.6%)Second/third trimester
2065 (100.0%)709 (100.0%)241 (100.0%)476 (100.0%)639 (100.0%)Total
aPoisson regression (P<.001) identifies a significant difference between the four study locations in the proportion of first trimester participants recruited
driven by the high proportion of Danish participants recruited in the first trimester.
Table 3 compares the ability of the five broad categories of paid
advertisement methods to recruit participants in their first
trimester. A second Poisson regression, which compared the
proportion of first trimester enrolled participants across three
of five advertisement categories (television- and social
media–recruited participants excluded due to small sample sizes)
identified a statistically significant difference (P<.001) driven
by the high proportion of total first trimester active participants
recruited by website advertisements (317/668, 47.5%) in
comparison with the email (72/995, 7.24%) and leaflet
advertisements (53/194, 27.3%). Although website
advertisements recruited the highest proportion of first trimester
participants overall, as they did in Denmark, Poland, and the
United Kingdom, in the Netherlands only 18.8% (6/32) of
participants recruited via website adverts were in their first
trimester compared with 41.2% (28/68) of leaflet recruited
participants.
Table 3. Overview of the number of study participants recruited in the first trimester (T1) by each of the paid advertisement methods stratified by study
location.
TotalUnited KingdomPolandNetherlandsDenmarkAdvertisement Methods
1867682125446614Total participants recruited by
paid advertising n
442 (23.7%)68 (10.0%)28 (22.4%)47 (9.87%)299 (48.7%)Total recruited in T1
n (% of total)
317/668 (47.5%)a7/20 (35.0%)8/22 (36.4%)6/32 (18.8%)296/594 (49.8%)Website n T1/total by method (%)
72/995 (7.2%)45/582 (7.7%)11/47 (23.4%)13/346 (3.8%)3/20 (15.0%)Email n T1/total by method (%)
53/194 (27.3%)16/79 (20.3%)9/47 (19.1%)28/68 (41.2%)-Leaflet n T1/total by method (%)
0/9 (0.0%)-0/9 (0.0%)--Television n T1/total by method (%)
0/1 (0.0%)0/1 (0.0%)---Paid Social Median T1/total by
method (%)
aPoisson regression (P<.001) identifies a significant difference in the proportion of first trimester study participants recruited between the website,
email, and leaflet advertisement methods, driven by the high proportion of first trimester participants recruited by website advertisements.
Discussion
Principal Findings
In this non-interventional study of self-reported gestational
exposures and pregnancy outcomes we found that low/no-cost
advertisements were unsuitable for recruiting a high number of
study participants in a short period of time. Higher-cost
advertisements improved recruitment considerably although
the costs were not insubstantial. Email and website
advertisements performed preferentially to the other methods
in terms of costs-per-participant recruited and overall website
advertisements were substantially superior at recruiting
participants in the first trimester. However, we did identify
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international variations in both the cost-effectiveness of the
various advertisement methods used and in their ability to recruit
participants in early pregnancy.
Advertisement Cost-Effectiveness
We believe that our study represents the first attempt to assess
the cost-effectiveness of direct-to-participant advertisement
methods used in the recruitment of women to a pregnancy PV
study. Available published data comparing the cost-effectiveness
of different advertisement methods to recruit pregnant women
to health research programs are limited [12,15,16]. One study
showed advertising via social media (€25.00 per participant,
based on 1,829,115 advert views over approximately 1 month,
624 clicks to the website, and 8 recruits) [15] to be more
cost-effective than in our study (€186.00, based on 135,305
advert views over one month, 236 clicks to the website, and 1
recruit). Results from a second study were more consistent with
our findings, suggesting that email advertising was the most
cost-effective of the methods trialed [16], although in contrast
to our findings website advertising was reported to be
approximately three times less cost-effective than email
advertising [16]. In addition, a final study identified a
considerable reduction in total research costs, including
recruitment costs, for studies conducted via the Internet in
comparison with more traditional researcher interview
techniques [12]. In this study, traditional researcher-led
recruitment costs were approximated at €33 per participant,
while Internet advertisement recruitment costs were lower than
what we experienced overall (€24.52) at €11.68 per participant
[12].
The key limitation of our cost-effectiveness analysis relates to
the inability to account for any cumulative exposure to various
advertisement materials. An additional limitation of the
international comparisons specifically relates to the way in
which we combined all the different advertisements used into
five broad categories. For example, the website advertisements
category combines cost-efficacy data from all the adverts placed
in various locations on a variety of sites all with different levels
of internet visibility (see Table 1). It is therefore plausible that
the number of unique site visitors, which viewed the adverts
varied between the websites that were grouped within this
category. While it might have been expected that this would be
controlled for by the cost of advertisement, with more prominent
websites charging higher costs, we found this wasn’t comparable
internationally. It was possible to advertise in prominent
positions on popular Danish websites at a lower cost than that
required for advertising on Dutch, Polish, or British websites
with similar levels of web visibility.
Recruitment of Participants in Early Pregnancy
One of the hypothesized advantages of collecting data from
pregnant women recruited directly without the requirement for
study promotion by a health care professional was that women
could theoretically be recruited early in pregnancy, prior to
seeking out any obstetric care. This was considered potentially
beneficial in that it could provide surveillance over a gestational
period not easily covered by traditional pregnancy PV/PE
studies, collecting early pregnancy exposure and outcome data,
which may otherwise be missed. Published data comparing the
demographics of pregnant participants recruited through
different advertisement methods are limited [17]. The single
published study that we identified [17] did not investigate the
differences in stage of pregnancy at enrollment for the various
advertisement methods used. We therefore believe that our
findings represent the first to demonstrate the variation in stage
of pregnancy at enrollment by advertisement method.
It is likely that a main factor predicting an advertisement
method’s ability to successfully recruit participants in early
pregnancy is the time at which women naturally interact with
the media platforms on which advertisements are displayed.
For example, email advertisements were mainly sent to
registered members of online pregnancy or parenting clubs;
although women in early pregnancy are not prevented from
registering with these, it is probable that most only do so in later
stages of gestation (>90 days post LMP – outside the first
trimester) when more confident that the pregnancy is likely to
continue to term. In contrast, pregnancy/parenting information
websites may be commonly viewed by women in the early
stages of pregnancy investigating pregnancy symptoms or using
due date calculators.
Overall the results of our study identified that website
advertisements recruited a significantly higher proportion of
women in early pregnancy in comparison with the alternative
methods. The results also identified a significant difference in
first trimester recruitment by study location, a finding that we
believe was mainly influenced by the high proportion of Danish
study participants which were recruited through website
advertising (~93%).
In this pilot study, most women were recruited beyond the first
trimester, but this is still of potential value for
direct-to-participant pregnancy PV/PE studies [18]. For example
details of early pregnancy maternal exposures and lifestyle
choices may still be collected, albeit retrospectively, and
therefore with a possible risk of introducing misclassification
or recall biases.
Future Research
For pregnancy PV studies specifically, the ability to detect
increased incidences of rare gestational events such as specific
congenital malformations among women taking a specific
medication is dependent on the enrolment of a large study
population. Prospective enrollment in early pregnancy is also
considered advantageous as it is likely to minimize the
introduction of some detrimental biases. Over the course of the
PROTECT pregnancy study’s 70-week recruitment period, we
conservatively estimate that more than 3 million pregnancies
would have been recognized by women residing in the four
study locations [19]. We therefore only enrolled a small
percentage of the total pregnant population, which raises
concerns regarding the ability of these methods to recruit a
sufficiently large enough sample size to test associations
between exposures and rare clinical events. In addition, the
advertisement methods we employed were much more likely
to recruit women in the later stages of pregnancy, which may
introduce selection, recall, and misclassification biases. While
we remain optimistic that study participant self-reporting of
medication use and obstetric outcomes will prove advantageous
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for pregnancy PV/PE studies, future research is needed to
identify advertisement strategies which are able to recruit large
numbers of demographically representative pregnant women,
preferably early in pregnancy and at a low cost. While the
recruitment strategy employed in this study aimed to exclusively
employ direct-to-participant advertisement methods, it is
possible that recruitment may be improved using study
promotion through clinicians such as general practitioners/family
doctors who are often the first health professional to speak to
patients about pregnancy.
Conclusions
Of the various advertisement methods trialed in this pilot study,
website and email advertisements were the most cost-effective,
while website advertisements were the most suitable for
enrolling participants in their first trimester. We believe these
findings could prove useful for researchers looking to recruit a
similar study cohort directly and without the intervention of
health care professionals or academic researchers. However,
our results also identify some concerns regarding the use of
direct-to-participant advertisement methods as the sole strategy
for recruiting women to a pregnancy PV study.
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